Actual Use of Medications Prescribed During Pregnancy: A Cross-Sectional Study Using Data from a Population-Based Congenital Anomaly Registry

Drug Safety

Volumn 38, Issue 8, 2015, Pages 737-747

  de Jonge, Linda ^a   de Walle, Hermien E K ^a   de Jong van den Berg, Lolkje T W ^b   van Langen, Irene M ^a   Bakker, Marian K ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIOLYTIC AGENT; CORTICOSTEROID; DERMATOLOGICAL AGENT; HYPNOTIC SEDATIVE AGENT; PRESCRIPTION DRUG;

ARTICLE; CONGENITAL MALFORMATION; CROSS-SECTIONAL STUDY; DATA ANALYSIS; DATA BASE; DISEASE REGISTRY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MEDICATION COMPLIANCE; NETHERLANDS; PATIENT COMPLIANCE; PHARMACY; PREGNANCY; PRESCRIPTION; PRIORITY JOURNAL; TELEPHONE INTERVIEW; ABNORMALITIES, DRUG-INDUCED; FACTUAL DATABASE; HEALTH SURVEY; NEWBORN; REGISTER;

ABNORMALITIES, DRUG-INDUCED; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; FEMALE; HUMANS; INFANT, NEWBORN; POPULATION SURVEILLANCE; PREGNANCY; PRESCRIPTION DRUGS; REGISTRIES;

EID: 84938214180     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.1007/s40264-015-0302-z     Document Type: Article

References (29)

1. Bakker MK, Jentink J, Vroom F, Den Van, Berg PB, De Walle HE, De Jong-Van Den Berg LT. Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in the Netherlands. BJOG. 2006;113:559–68.
2. Van Spall HG, Toren A, Kiss A, Fowler RA. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA. 2007;297:1233–40.
3. Jentink J, Loane MA, Dolk H, Barisic I, Garne E, Morris JK, De Jong-van den Berg LT, for the EUROCAT Antiepileptic Study Working Group. Valproic acid monotherapy in pregnancy and major congenital malformations. N Engl J Med. 2010;362:2185–93.
4. De Jonge L, Bos HJ, Van Langen IM, De Jong-Van Den Berg LT, Bakker MK. Antibiotics prescribed before, during and after pregnancy in the Netherlands: a medication utilization study. Pharmacoepidemiol Drug Saf. 2014;3:60–8.
5. Olesen C, Sondergaard C, Thrane N, Nielsen GL, De Jong-Van Den Berg LT, Olsen J. Do pregnant women report use of dispensed medicines? Epidemiology. 2001;12:497–501.
6. Graham DJ, Smith CR. Misclassification in epidemiologic studies of adverse medication reactions using large managerial data bases. Am J Prev Med. 1988;4:15–24.
7. De Jonge L, Zetstra-Van Der Woude PA, Bos HJ, De Jong-Van Den Berg LT, Bakker MK. Identifying associations between maternal medication use and birth defects using a case-population approach: an exploratory study on signal detection. Drug Saf. 2013;36:1069–78.
8. Li DK, Yang C, Andrade S, Tavares V, Ferber JR. Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study. BMJ. 2011;18:343.
9. Eurocat Northern Netherlands. In: General figures. 2014. http://www.rug.nl/research/genetics/eurocat/pdf/general-figures-2014.pdf. Accessed 9 Dec 2014.
10. Centraal Bureau voor de Statistiek. In: StatLine. 2014. http://statline.cbs.nl/StatWeb/publication/?VW=T&DM=SLNL&PA=37422ned&D1=0,4-5,7,9,11,13,17,26,35,40-41&D2=0,10,20,30,40,(l-4)-l&HD=090218-0953&HDR=G1&STB=T. Accessed 9 Dec 2014.
11. Greenlees R, Neville A, Addor MC, et al. Paper 6: EUROCAT member registries: organization and activities. Birth Defects Res A Clin Mol Teratol. 2011;91:S51–100.
12. Bakker MK. Introduction—Eurocat of M. K. Bakker’s dissertation: ‘The use of a birth defects case-control monitoring system in studying the safety of medication in pregnancy’. http://dissertations.ub.rug.nl/faculties/medicine/2010/m.k.bakker/. Accessed 10 Dec 2014.
13. World Health Organization Collaborating Centre for Drug Statistics Methodology. In: ATC/DDD Index 2012. 2012. http://www.whocc.no/atcddd. Accessed 14 Aug 2012.
14. Department of Epidemiology. In: Help!Statistiek! 2009. http://www.rug.nl/research/epidemiology/downloadarea/helpstat19.pdf. Accessed 3 Oct 2014.
15. Jin J, Sklar GE, Min Sen Oh V, ChuenLi S. Factors affecting therapeutic compliance: a review from the patient’s perspective. Ther Clin Risk Manag. 2008;4:269–86.
16. Sabaté E, editor. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.
17. DiMatteo MR. Patient adherence to pharmacotherapy: the importance of effective communication. Formulary. 1995;30:596–8, 601–2, 605.
18. De Jong-Van Den Berg LT, Waardenburg CM, Haaijer-Ruskamp FM, Dukes MN, Wesseling H. Drug use in pregnancy: a comparative appraisal of data collecting methods. European Journal of Clinical Pharmacology. 1993;45:9–14.
19. Van Gelder MM, van Rooij IA, de Walle HE, Roeleveld N, Bakker MK. Maternal recall of prescription medication use during pregnancy using a paper-based questionnaire: a validation study in the Netherlands. Drug Saf. 2013;36:43–54.
20. Mitchell AA, Cottler LB, Shapiro S. Effect of questionnaire design on recall of medication exposure in pregnancy. Am J Epidemiol. 1986;123:670–6.
21. Bryant HE, Visser N, Love EJ. Records, recall loss, and recall bias in pregnancy: a comparison of interview and medical records data of pregnant and postnatal mothers. Am J Public Health. 1989;79:78–80.
22. Cornish PL, Knowles SR, Marchesano R, Tam V, Shadowitz S, Juurlink DN, Etchells EE. Unintended medication discrepancies at the time of hospital admission. Arch Intern Med. 2005;165:424–9.
23. Beers MH, Munekata M, Storrie M. The accuracy of medication histories in the hospital medical records of elderly persons. J Am Geriatr Soc. 1990;38:1183–7.
24. Sen A. Health: perception versus observation. BMJ. 2002;324:860–1.
25. Newport DJ, Brennan PA, Green P, Ilardj D, Whitfield TH, Morris N, Knight BT, Stowe ZN. Maternal depression and medication exposure during pregnancy: comparison of maternal retrospective recall to prospective documentation. BJOG. 2008;115:681–8.
26. Brent RL. Addressing environmentally caused human birth defects. Pediatr Rev. 2001;22:153–65.
27. Grzeskowiak LE, Gilbert AL, Morrison JL. Exposed or not exposed? Exploring exposure classification in studies using administrative data to investigate outcomes following medication use during pregnancy. Eur J Clin Pharmacol. 2012;68:459–67.
28. Chambers K. Asthma education and outcomes for women of childbearing age. Case Manager. 2003;14:58–61.
29. Rockenbauer M, Olsen J, Czeizel AE, Pedersen L, Sorensen HT, EuroMAP Group. Recall bias in a case-control surveillance system on the use of medicine during pregnancy. Epidemiology. 2001;12:461–6.